311 related articles for article (PubMed ID: 31060889)
1. The clinical and histopathological features of idiopathic inflammatory myopathies with asymmetric muscle involvement.
Liu M; Hou Y; Dai T; Lv J; Li W; Zhao Y; Fang Q; Yan C
J Clin Neurosci; 2019 Jul; 65():46-53. PubMed ID: 31060889
[TBL] [Abstract][Full Text] [Related]
2. Immune-mediated necrotizing myopathy (IMNM): A myopathological challenge.
Merlonghi G; Antonini G; Garibaldi M
Autoimmun Rev; 2022 Feb; 21(2):102993. PubMed ID: 34798316
[TBL] [Abstract][Full Text] [Related]
3. Idiopathic inflammatory myopathies in adults: A comparative study of Bohan and Peter and European Neuromuscular Center 2004 criteria.
Challa S; Jakati S; Uppin MS; Kannan MA; Liza R; Murthy Jagarlapudi MK
Neurol India; 2018; 66(3):767-771. PubMed ID: 29766941
[TBL] [Abstract][Full Text] [Related]
4. Major histocompatibility complex class I and II detection as a diagnostic tool in idiopathic inflammatory myopathies.
Jain A; Sharma MC; Sarkar C; Bhatia R; Singh S; Handa R
Arch Pathol Lab Med; 2007 Jul; 131(7):1070-6. PubMed ID: 17616993
[TBL] [Abstract][Full Text] [Related]
5. Idiopathic inflammatory myopathies with anti-mitochondrial antibodies: Clinical features and treatment outcomes in a Chinese cohort.
Hou Y; Liu M; Luo YB; Sun Y; Shao K; Dai T; Li W; Zhao Y; Yan C
Neuromuscul Disord; 2019 Jan; 29(1):5-13. PubMed ID: 30579751
[TBL] [Abstract][Full Text] [Related]
6. [Clinical and histopathological features of myositis associated with anti-mitochondrial antibodies].
Shimizu J
Rinsho Shinkeigaku; 2013; 53(11):1114-6. PubMed ID: 24291896
[TBL] [Abstract][Full Text] [Related]
7. Revisiting Pathological Classification Criteria for Adult Idiopathic Inflammatory Myopathies: In-Depth Analysis of Muscle Biopsies and Correlation Between Pathological Diagnosis and Clinical Manifestations.
Hou Y; Luo YB; Dai T; Shao K; Li W; Zhao Y; Lu JQ; Yan C
J Neuropathol Exp Neurol; 2018 May; 77(5):395-404. PubMed ID: 29522204
[TBL] [Abstract][Full Text] [Related]
8. The Clinical and Histological Spectrum of Idiopathic Inflammatory Myopathies.
Cavazzana I; Fredi M; Selmi C; Tincani A; Franceschini F
Clin Rev Allergy Immunol; 2017 Feb; 52(1):88-98. PubMed ID: 26514357
[TBL] [Abstract][Full Text] [Related]
9. [Idiopathic inflammatory myopathies from the viewpoint of a neurologist].
Shimizu J
Brain Nerve; 2013 Nov; 65(11):1269-74. PubMed ID: 24200604
[TBL] [Abstract][Full Text] [Related]
10. The pattern of MHC class I expression in muscle biopsies from patients with myositis and other neuromuscular disorders.
Milisenda JC; Pinal-Fernandez I; Lloyd TE; Grau-Junyent JM; Christopher-Stine L; Corse AM; Mammen AL
Rheumatology (Oxford); 2023 Sep; 62(9):3156-3160. PubMed ID: 36707996
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological and circulating cell-free DNA profile in myositis associated with anti-mitochondrial antibody.
Wang Y; Zhao Y; Yu M; Wei L; Zhang W; Wang Z; Yuan Y
Ann Clin Transl Neurol; 2023 Nov; 10(11):2127-2138. PubMed ID: 37723899
[TBL] [Abstract][Full Text] [Related]
12. Polymyositis and dermatomyositis - challenges in diagnosis and management.
Yang SH; Chang C; Lian ZX
J Transl Autoimmun; 2019 Dec; 2():100018. PubMed ID: 32743506
[TBL] [Abstract][Full Text] [Related]
13. Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy.
Watanabe Y; Uruha A; Suzuki S; Nakahara J; Hamanaka K; Takayama K; Suzuki N; Nishino I
J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1038-44. PubMed ID: 27147697
[TBL] [Abstract][Full Text] [Related]
14. Clinical Characteristics of Anti-3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Antibodies in Chinese Patients with Idiopathic Inflammatory Myopathies.
Ge Y; Lu X; Peng Q; Shu X; Wang G
PLoS One; 2015; 10(10):e0141616. PubMed ID: 26509687
[TBL] [Abstract][Full Text] [Related]
15. Clinical and pathological features of immune-mediated necrotising myopathies in a single-centre muscle biopsy cohort.
Yang H; Tian X; Zhang L; Li W; Liu Q; Jiang W; Peng Q; Wang G; Lu X
BMC Musculoskelet Disord; 2022 May; 23(1):425. PubMed ID: 35524238
[TBL] [Abstract][Full Text] [Related]
16. Clinical features and diagnostic tools in idiopathic inflammatory myopathies.
Tsamis KI; Boutsoras C; Kaltsonoudis E; Pelechas E; Nikas IP; Simos YV; Voulgari PV; Sarmas I
Crit Rev Clin Lab Sci; 2022 Jun; 59(4):219-240. PubMed ID: 34767470
[TBL] [Abstract][Full Text] [Related]
17. Immune-Mediated Necrotizing Myopathy: Update on Diagnosis and Management.
Basharat P; Christopher-Stine L
Curr Rheumatol Rep; 2015 Dec; 17(12):72. PubMed ID: 26515574
[TBL] [Abstract][Full Text] [Related]
18. Muscle pathological features and extra-muscle involvement in idiopathic inflammatory myopathies with anti-mitochondrial antibody.
Zhang L; Yang H; Lei J; Peng Q; Yang H; Wang G; Lu X
Semin Arthritis Rheum; 2021 Aug; 51(4):741-748. PubMed ID: 34144384
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and classification of idiopathic inflammatory myopathies.
Lundberg IE; Miller FW; Tjärnlund A; Bottai M
J Intern Med; 2016 Jul; 280(1):39-51. PubMed ID: 27320359
[TBL] [Abstract][Full Text] [Related]
20. The immunoproteasomes are key to regulate myokines and MHC class I expression in idiopathic inflammatory myopathies.
Bhattarai S; Ghannam K; Krause S; Benveniste O; Marg A; de Bruin G; Xin BT; Overkleeft HS; Spuler S; Stenzel W; Feist E
J Autoimmun; 2016 Dec; 75():118-129. PubMed ID: 27522114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
